These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Early impact of the Japanese immunization program implemented before the HPV vaccination crisis. Matsumoto K; Yaegashi N; Iwata T; Yamamoto K; Nagashima M; Saito T; Ushijima K; Takahashi F; Noda K; Yoshikawa H Int J Cancer; 2017 Oct; 141(8):1704-1706. PubMed ID: 28657110 [No Abstract] [Full Text] [Related]
3. Struggles within Japan's national HPV vaccination: A proposal for future strategy. Tanaka Y; Ueda Y; Kimura T Hum Vaccin Immunother; 2017 May; 13(5):1167-1168. PubMed ID: 28059676 [No Abstract] [Full Text] [Related]
4. A behavioral economics approach to the failed HPV vaccination program in Japan. Yagi A; Ueda Y; Kimura T Vaccine; 2017 Dec; 35(50):6931-6933. PubMed ID: 29150210 [No Abstract] [Full Text] [Related]
5. Health problems most commonly diagnosed among young female patients during visits to general practitioners and gynecologists in France before the initiation of the human papillomavirus vaccination program. Van Ganse E; Letrilliart L; Borne H; Morand F; Robain M; Siegrist CA Pharmacoepidemiol Drug Saf; 2012 Mar; 21(3):261-8. PubMed ID: 22052698 [TBL] [Abstract][Full Text] [Related]
6. [HPV Vaccination Program - The History and Recent Progress]. Yoshikawa H Gan To Kagaku Ryoho; 2017 Sep; 44(9):713-716. PubMed ID: 28912394 [TBL] [Abstract][Full Text] [Related]
7. HPV related surveillance activities in Australia. Brotherton J; Kaldor JM; McIntyre P Vaccine; 2010 Nov; 28(47):7453-4. PubMed ID: 20854898 [No Abstract] [Full Text] [Related]
8. Safety of HPV vaccines in the age of nonavalent vaccination. Quattrone F; Canale A; Filippetti E; Tulipani A; Porretta A; Lopalco PL Minerva Pediatr; 2018 Feb; 70(1):59-66. PubMed ID: 29363293 [TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus vaccine introduction--the first five years. Markowitz LE; Tsu V; Deeks SL; Cubie H; Wang SA; Vicari AS; Brotherton JM Vaccine; 2012 Nov; 30 Suppl 5():F139-48. PubMed ID: 23199957 [TBL] [Abstract][Full Text] [Related]
10. HPV vaccination programme in Japan. Gilmour S; Kanda M; Kusumi E; Tanimoto T; Kami M; Shibuya K Lancet; 2013 Aug; 382(9894):768. PubMed ID: 23993189 [No Abstract] [Full Text] [Related]
11. HPV vaccination in head and neck HPV-related pathologies. Wierzbicka M; Józefiak A; Jackowska J; Szydłowski J; Goździcka-Józefiak A Otolaryngol Pol; 2014; 68(4):157-73. PubMed ID: 24981297 [TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). Markowitz LE; Dunne EF; Saraiya M; Chesson HW; Curtis CR; Gee J; Bocchini JA; Unger ER; MMWR Recomm Rep; 2014 Aug; 63(RR-05):1-30. PubMed ID: 25167164 [TBL] [Abstract][Full Text] [Related]
14. Compensation programs after withdrawal of the recommendation for HPV vaccine in Japan. Yuji K; Nakada H Hum Vaccin Immunother; 2016 May; 12(5):1321-4. PubMed ID: 26513303 [TBL] [Abstract][Full Text] [Related]
15. Human Papillomavirus Vaccination Requirements in US Schools: Recommendations for Moving Forward. North AL; Niccolai LM Am J Public Health; 2016 Oct; 106(10):1765-70. PubMed ID: 27552264 [TBL] [Abstract][Full Text] [Related]
16. Bug breakfast in the bulletin: the early impact of the national HPV vaccination program. Quinn E; Donovan B; Sheppeard VK N S W Public Health Bull; 2012 Dec; 23(9-10):208. PubMed ID: 23442998 [No Abstract] [Full Text] [Related]
17. Systematic review of human papillomavirus vaccine coadministration. Noronha AS; Markowitz LE; Dunne EF Vaccine; 2014 May; 32(23):2670-4. PubMed ID: 24412351 [TBL] [Abstract][Full Text] [Related]
18. The Expanded Impact of Human Papillomavirus Vaccine. Pahud BA; Ault KA Infect Dis Clin North Am; 2015 Dec; 29(4):715-24. PubMed ID: 26610422 [TBL] [Abstract][Full Text] [Related]